FaCellitate Overview

  • Year Founded
  • 2021

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 13

Employees

  • Latest Deal Type
  • M&A

FaCellitate General Information

Description

Developer of biomedical technology designed to support cancer and stem cell research, drug discovery, toxicology, and tissue engineering. The company offers chemically defined, animal- and xeno-free cell culture coatings for 3D cell culture and stem cell research, enabling researchers to run experiments on smart lab surfaces.

Contact Information

Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Formerly VC-backed
Corporate Office
  • Franz-Volhard-Straße 5
  • 68167 Mannheim
  • Germany
+49 0621
Primary Industry
Discovery Tools (Healthcare)
Other Industries
Biotechnology
Electronic Equipment and Instruments
Medical Supplies
Parent Company
Sarstedt
Corporate Office
  • Franz-Volhard-Straße 5
  • 68167 Mannheim
  • Germany
+49 0621

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

FaCellitate Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Merger/Acquisition 16-Nov-2026 Completed Generating Revenue
5. Secondary Transaction - Private Completed Generating Revenue
4. Accelerator/Incubator 13-Apr-2024 Completed Generating Revenue
3. Seed Round 07-Sep-2022 Completed Generating Revenue
2. Accelerator/Incubator 01-Jan-2022 Completed Generating Revenue
1. Spin-Off 01-Jan-2021 Completed Generating Revenue
To view FaCellitate’s complete valuation and funding history, request access »

FaCellitate Patents

FaCellitate Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2024225071-A1 Cell attachment polymer conjugate Pending 23-Feb-2023
EP-4669741-A1 Cell attachment polymer conjugate Pending 23-Feb-2023
WO-2024175790-A1 Cell attachment polymer conjugate Inactive 23-Feb-2023
WO-2023089165-A1 Photobioreactor with an adsorbed layer of antifouling cationic comb copolymer Inactive 22-Nov-2021
WO-2023089167-A1 Photobioreactor with an adsorbed layer of antifouling zwitterionic copolymer Inactive 22-Nov-2021 C12M21/02
To view FaCellitate’s complete patent history, request access »

FaCellitate Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

FaCellitate Former Investors (8)

Investor Name Investor Type Holding Investor Since Participating Rounds
Arve Capital Venture Capital Minority
Chemovator Accelerator/Incubator Minority
German Accelerator Accelerator/Incubator
High-Tech Gründerfonds Venture Capital Minority
NEXT Mannheim Accelerator/Incubator
You’re viewing 5 of 8 investors. Get the full list »

FaCellitate FAQs

  • When was FaCellitate founded?

    FaCellitate was founded in 2021.

  • Where is FaCellitate headquartered?

    FaCellitate is headquartered in Mannheim, Germany.

  • What is the size of FaCellitate?

    FaCellitate has 13 total employees.

  • What industry is FaCellitate in?

    FaCellitate’s primary industry is Discovery Tools (Healthcare).

  • Is FaCellitate a private or public company?

    FaCellitate is a Private company.

  • What is FaCellitate’s current revenue?

    The current revenue for FaCellitate is .

  • How much funding has FaCellitate raised over time?

    FaCellitate has raised $3.72M.

  • Who are FaCellitate’s investors?

    Arve Capital, Chemovator, German Accelerator, High-Tech Gründerfonds, and NEXT Mannheim are 5 of 8 investors who have invested in FaCellitate.

  • When was FaCellitate acquired?

    FaCellitate was acquired on 16-Nov-2026.

  • Who acquired FaCellitate?

    FaCellitate was acquired by Sarstedt.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process